<?xml version="1.0" encoding="UTF-8"?>
<p id="p0050">We also compared expression of sodium iodide symporter gene 
 <italic>SLC5A5</italic> in the biosamples from tumors, which were resistant to radioactive iodine therapy, with all other thyroid tumors profiled in this study. In line with the previous data [
 <xref rid="bib33" ref-type="bibr">33</xref>, 
 <xref rid="bib34" ref-type="bibr">34</xref>, 
 <xref rid="bib35" ref-type="bibr">35</xref>], in our dataset 
 <italic>SLC5A5</italic> was statistically significantly downregulated (p = 3.44∗10
 <sup>−3</sup>) in radioactive iodine-resistant tumor samples (
 <xref rid="fig2" ref-type="fig">Figure 2</xref>).
</p>
